Beng Yang

Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Corrigendum to "Identification of pyroptosis-related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in pancreatic cancer" [Hepatobiliary Pancreat Dis Int 24 (2025) 579-585].

Corrigendum to "Identification of pyroptosis-related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in pancreatic cancer" [Hepatobiliary Pancreat Dis Int 24 (2025) 579-585].

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: July 23, 2026

β-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma.

β-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma.

Journal: Journal for immunotherapy of cancer

Published: July 22, 2026

GPC3-based circular RNA vaccine suppresses hepatocellular carcinoma progression by activating adaptive immune responses.

GPC3-based circular RNA vaccine suppresses hepatocellular carcinoma progression by activating adaptive immune responses.

Journal: Hepatology (Baltimore, Md.)

Published: December 18, 2024

The effect of TIM1+ Breg cells in liver ischemia-reperfusion injury.

The effect of TIM1+ Breg cells in liver ischemia-reperfusion injury.

Journal: Cell death & disease

Published: September 05, 2024

Identification of pyroptosis-related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in pancreatic cancer.

Identification of pyroptosis-related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in pancreatic cancer.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: March 05, 2024

MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer.

MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer.

Journal: International journal of oncology

Published: January 26, 2024

Co-Delivery of siNRF2 and Sorafenib by a "Click" Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma.

Co-Delivery of siNRF2 and Sorafenib by a "Click" Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: November 20, 2023

Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21-Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis.

Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21-Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 20, 2023

IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma.

IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma.

Journal: Cancer letters

Published: August 14, 2023

Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis.

Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis.

Journal: Cell death & disease

Published: June 14, 2023

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion.

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 14, 2022

MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma.

MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma.

Journal: Biochemical and biophysical research communications

Published: September 29, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026